跳至主要内容
临床试验/NCT02352090
NCT02352090已完成4 期

Synthetic vs Natural Estrogen in Combined Oral Contraception- Effect on Insulin Sensitivity, Coagulation, Inflammation and Endometrium - a Comparison With a Progestin-only Preparation.

Helsinki University Central Hospital2 个研究点 分布在 1 个国家目标入组 59 人开始时间: 2015年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
59
试验地点
2
主要终点
Matsuda Index- Whole Body Insulin Sensitivity Index

研究概览

简要总结

The main objective of the study is to compare the metabolic effects of natural estradiol and synthetic ethinylestradiol used in combined oral contraception in healthy women. A progestin-only preparation will be used in comparison. The main goal is to study the effects on glucose metabolism, coagulation and a markers of chronic inflammation (such as hs-CRP). Our hypothesis is that the natural estradiol preparation will influence blood glucose levels, markers of coagulation and chronic inflammation less than the ethinylestradiol preparation. The progestin-only preparation will not effect these parameters.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • BMI 19-24.9, regular menstrual cycles (21-35 days), a minimum of 2 months without any hormonal contraceptives, no contraindications for use of hormonal contraception

排除标准

  • Polycystic ovaries, hypertension, smoking, alcohol abuse, pregnancy, lactation, abnormal result in pre-screening 2h oral glucose tolerance test, regular medications

研究组 & 干预措施

Synthetic estrogen + progestin

Experimental

Ethinyl estradiol / dienogest

干预措施: Ethinyl estradiol / dienogest (Drug)

Natural estrogen + progestin

Experimental

Estradiol valerate / dienogest

干预措施: Estradiol valerate / dienogest (Drug)

Progestin-Only

Active Comparator

Dienogest

干预措施: Dienogest (Drug)

结局指标

主要结局

Matsuda Index- Whole Body Insulin Sensitivity Index

时间窗: We calculated the change in Matsuda index from baseline to 9 weeks.

Matsuda index is calculated from the standard 2h Oral Glucose Tolerance Test and corresponding insulin values. Matsuda index = 10,000/square root of \[fasting glucose x fasting insulin\] x \[mean glucose x mean insulin during OGTT\]) The Matsuda index is correlated (r = 0.73) with the rate of whole-body glucose disposal during the euglycemic insulin clamp. Matsuda index \<2.5 is considered insulin resistant, higher values indicate less insulin resistance. A decrease in matsuda index over the study period would indicate decreased insulin sensitivity.

次要结局

  • Low-Density Lipoprotein (LDL)(baseline and 9 weeks)
  • Triglyceride(baseline and 9 weeks)
  • F1+2(baseline and 9 weeks)
  • High-sensitivity C Reactive Protein(baseline and 9 weeks)
  • Total Cholesterol(baseline and 9 weeks)
  • D-dimer(baseline and 9 weeks)
  • Fasting Insulin(baseline and 9 weeks)
  • High-Density Lipoprotein (HDL)(baseline and 9 weeks)
  • Thrombin Generation, ETP Endogenous Thrombin Potential(baseline and 9 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Annina Haverinen

MD

Helsinki University Central Hospital

研究点 (2)

Loading locations...

相似试验